Neoadjuvant disitamab vedotin plus perioperative toripalimab showed promising efficacy and acceptable safety in patients with HER2-expressing MIBC, according to Xinan Sheng, MD.

A man in his 50s presented to the emergency department with a complaint of progressively increasing swelling in the lower abdomen. Investigations revealed a large pelvic mass for which a fine needle ...

Discover a study that found that the combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible ...

Endometriosis, a condition where tissue similar to uterine tissue grows outside the uterus, affects many women in the ...

Dr. Chandler Park helps patients with genitourinary cancers, including both prostate and bladder, understand the importance ...